Showing 1071-1080 of 20387 results for "".
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
https://reachmd.com/programs/cme/future-proofing-in-hae-advances-in-long-term-prophylaxis-to-prevent-attacks-and-improve-quality-of-life/54448/On-demand webcast with expert faculty presentation on addressing the unmet needs and optimizing treatment for hereditary angioedema (HAE), including long-term prophylaxis therapy, for patients with HAE.Breaking the Cycle: Prioritizing Weight Loss to Improve OSA Management
https://reachmd.com/programs/cme/breaking-the-cycle-prioritizing-weight-loss-to-improve-osa-management/48715/On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strategies for prioritizing weight loss to improve OSA management among select patients.Managing Adverse Events Associated With Menin Inhibitors
https://reachmd.com/programs/cme/managing-adverse-events-associated-with-menin-inhibitors/36182/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Frontline Insights: Emerging Therapeutic Strategies in HNSCC
https://reachmd.com/programs/cme/Frontline-Insights-Emerging-Therapeutic-Strategies-in-HNSCC/49223/Review emerging therapeutic strategies in HNSCC across disease states and learn to compare safety profile to improve AE recognition, prevention, and management.ATTRibute-CM: Insights from ESC HF
https://reachmd.com/clinical-practice/cardiology/attribute-cm-insights-from-esc-hf/57173/Examine outpatient worsening heart failure in ATTR-CM and the clinical implications of data presented at ESC HFPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 3
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-3/56871/In the third installment of a nine-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, analyze key study results, highlighting improvements in body surface area, lesion characteristics, and quality of life with adjunctive skincare use.1 DPractical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases, Ch. 8
https://reachmd.com/programs/the-practical-dermatology-roundtable/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-8/56876/In the eighth installment of this eight-part series, host Ted Lain, MD, MBA, FAAD, and guests Zoe Diana Draelos, MD, and Firas George Hougeir, MD, FAAD, answer audience questions on practical management topics such as treating ear canal psoriasis, addressing itch, and managing scalp involvement.Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
https://reachmd.com/programs/cme/Precision-Starts-Before-Birth-Reimagining-Fetal-Care-Through-FcRn-Immune-Modulation/37099/Explore FcRn inhibition as a preventive strategy for HDFN and FNAIT, with focus on ongoing trials including AZALEA and FREESIA.Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
https://reachmd.com/programs/cme/partnering-with-patients-improving-first-line-treatment-selection-in-upper-gi-cancers-through-shared-decision-making/36579/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingSeltorexant vs Quetiapine XR in MDD With Insomnia: A 26-Week Phase 3 Comparison
https://reachmd.com/clinical-practice/psychiatry-and-mental-health/seltorexant-vs-quetiapine-xr-in-mdd-with-insomnia-a-26-week-phase-3-comparison/37644/Compare efficacy, safety, and tolerability of adjunctive seltorexant versus quetiapine XR in MDD patients with insomnia symptoms.